- 2019
-
Press releases - 17.10.2019
Aging with HIV Linked to Increased Risk of Cognitive Impairment
Thanks to antiretroviral therapies, it is possible to grow old with HIV under control. However, this chronic infection may not leave cognitive function unscathed. That is why Alain Makinson (Translational Research on HIV and Infectious Diseases unit, Montpellier University Hospital, Université de Montpellier, Inserm, IRD) and his team were interested in exploring the development of neurocognitive impairment (NCI), such as diminished attention, memory and motor capacity, in patients living with HIV in the ANRS EP58 HAND 55-70 study.
-
Press releases - 14.10.2019
Science serves gender equality
Researchers explain how a neuroscientific approach can be used to more effectively combat gender inequality. The actions taken by the researchers have increased the number of female speakers invited to take the floor at the research center from 25 to 44% in the space of a year and a half, and have increased the number of women in senior roles from 25 to 31%. Their neuroscience-based approach now constitutes an important mechanism for changing attitudes and behaviors. Among other things, their future work will focus on using “nudges”—a technique originating in neuroscience that tries to influence our behavior in our own interest—to improve gender equality. An example for others to follow.
-
Press releases - 09.10.2019
Hormone therapy has a bigger impact than chemotherapy on women’s quality of life
Analysis of the CANTO cohort published in the journal Annals of Oncology will upset received wisdom on the effects that hormone therapy and chemotherapy have on the quality of life in women with breast cancer. Contrary to the commonly held view, 2 years after diagnosis, hormone therapy, a highly effective breast cancer treatment worsens quality of life to a greater extent and for a longer time, especially in menopausal patients. The deleterious effects of chemotherapy are more transient.
-
Press releases - 07.10.2019
Atopic dermatitis: how allergens get on our nerves
Atopic dermatitis, or eczema, primarily affects infants and children, and manifests itself in hypersensitivity to allergens in the environment. A skin disease characterized by flare-ups, it is often treated with topical anti-inflammatories. A new study shows that immune cells and sensory neurons interact in the skin to form units that can detect allergens and trigger inflammation. A discovery that provides an insight into how atopic dermatitis works, and points the way to new therapeutic possibilities.
-
Press releases - 04.10.2019
Nobel prize 2019
The 2019 Nobel Prize was awarded on Monday, October 7
-
What's on? - 04.10.2019
Nobel prize 2019
Only available in french
-
Press releases - 03.10.2019
Dysentery: Shigella, bacteria with adaptation to respiration
Bacillary dysentery caused by the intestinal bacteria Shigella is a major health problem in tropical regions and developing countries. Complications from this infection lead to several hundred thousand deaths a year, primarily among infants. Researchers from Inserm and the Institut Pasteur have studied the mechanisms of Shigella virulence. They found that these bacteria are not only able to consume the oxygen in colonic tissue in order to grow and create foci of infection, but can also adapt their mode of respiration so that they can continue to grow once the oxygen in these foci has been used up.
-
Press releases - 26.09.2019
Sport Has Its Benefits but Do Not Overdo It
A study shows that intensive physical training can harm brain capacity, particularly cognitive control.
-
Press releases - 25.09.2019
Identified: A Protein Essential for Chikungunya Virus Replication
Chikungunya is characterized by high fever and intense joint and muscle pain that can last for several months. The mechanisms of infection of human cells with the virus remain very poorly understood. Led by Ali Amara in collaboration with Marc Lecuit researchers from Inserm, Institut Pasteur, CNRS and Université de Paris have identified a protein that is crucial in order for the virus to replicate within its target cells.
-
Press releases - 24.09.2019
Disarming a probiotic to improve its benefits
In a recent study, researchers managed to decipher certain pathways by which Escherichia coli Nissle 1917 produces both beneficial and toxic compounds. They then successfully created a modified strain with the same probiotic properties but an unactivated version of the toxin.